Cargando…
Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function
BACKGROUND: CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270019/ https://www.ncbi.nlm.nih.gov/pubmed/22312424 http://dx.doi.org/10.1371/journal.pone.0030330 |
_version_ | 1782222535476117504 |
---|---|
author | Curriu, Marta Fausther-Bovendo, Hughes Pernas, María Massanella, Marta Carrillo, Jorge Cabrera, Cecilia López-Galíndez, Cecilio Clotet, Bonaventura Debré, Patrice Vieillard, Vincent Blanco, Julià |
author_facet | Curriu, Marta Fausther-Bovendo, Hughes Pernas, María Massanella, Marta Carrillo, Jorge Cabrera, Cecilia López-Galíndez, Cecilio Clotet, Bonaventura Debré, Patrice Vieillard, Vincent Blanco, Julià |
author_sort | Curriu, Marta |
collection | PubMed |
description | BACKGROUND: CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate Env cytopathic mechanisms may be modified in such situation. METHODS: We identified untreated HIV-infected individuals showing non-cytopathic replication (VL>10,000 copies/mL and CD4 T-cell decay<50 cells/µL/year, Viremic Non Progressors, VNP) or rapid progression (CD4 T-cells<350 cells/µL within three years post-infection, RP). We isolated full-length Env clones and analyzed their functions (tropism, fusion activity and capacity to induce NKp44L expression on CD4 cells). Anti-Env humoral responses were also analyzed. RESULTS: Env clones isolated from VNP or RP individuals showed no major phenotypic differences. The percentage of functional clones was similar in both groups. All clones tested were CCR5-tropic and showed comparable expression and fusogenic activity. Moreover, no differences were observed in their capacity to induce NKp44L expression on CD4 T cells from healthy donors through the 3S epitope of gp41. In contrast, anti- Env antibodies showed clear functional differences: plasma from VNPs had significantly higher capacity than RPs to block NKp44L induction by autologous viruses. Consistently, CD4 T-cells isolated from VNPs showed undetectable NKp44L expression and specific antibodies against a variable region flanking the highly conserved 3S epitope were identified in plasma samples from these patients. Conversely, despite continuous antigen stimulation, VNPs were unable to mount a broad neutralizing response against HIV. CONCLUSIONS: Env functions (fusion and induction of NKp44L) were similar in viremic patients with slow or rapid progression to AIDS. However, differences in humoral responses against gp41 epitopes nearby 3S sequence may contribute to the lack of CD4 T cell decay in VNPs by blocking the induction of NKp44L by gp41. |
format | Online Article Text |
id | pubmed-3270019 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-32700192012-02-06 Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function Curriu, Marta Fausther-Bovendo, Hughes Pernas, María Massanella, Marta Carrillo, Jorge Cabrera, Cecilia López-Galíndez, Cecilio Clotet, Bonaventura Debré, Patrice Vieillard, Vincent Blanco, Julià PLoS One Research Article BACKGROUND: CD4 T-cell decay is variable among HIV-infected individuals. In exceptional cases, CD4 T-cell counts remain stable despite high plasma viremia. HIV envelope glycoprotein (Env) properties, namely tropism, fusion or the ability to induce the NK ligand NKp44L, or host factors that modulate Env cytopathic mechanisms may be modified in such situation. METHODS: We identified untreated HIV-infected individuals showing non-cytopathic replication (VL>10,000 copies/mL and CD4 T-cell decay<50 cells/µL/year, Viremic Non Progressors, VNP) or rapid progression (CD4 T-cells<350 cells/µL within three years post-infection, RP). We isolated full-length Env clones and analyzed their functions (tropism, fusion activity and capacity to induce NKp44L expression on CD4 cells). Anti-Env humoral responses were also analyzed. RESULTS: Env clones isolated from VNP or RP individuals showed no major phenotypic differences. The percentage of functional clones was similar in both groups. All clones tested were CCR5-tropic and showed comparable expression and fusogenic activity. Moreover, no differences were observed in their capacity to induce NKp44L expression on CD4 T cells from healthy donors through the 3S epitope of gp41. In contrast, anti- Env antibodies showed clear functional differences: plasma from VNPs had significantly higher capacity than RPs to block NKp44L induction by autologous viruses. Consistently, CD4 T-cells isolated from VNPs showed undetectable NKp44L expression and specific antibodies against a variable region flanking the highly conserved 3S epitope were identified in plasma samples from these patients. Conversely, despite continuous antigen stimulation, VNPs were unable to mount a broad neutralizing response against HIV. CONCLUSIONS: Env functions (fusion and induction of NKp44L) were similar in viremic patients with slow or rapid progression to AIDS. However, differences in humoral responses against gp41 epitopes nearby 3S sequence may contribute to the lack of CD4 T cell decay in VNPs by blocking the induction of NKp44L by gp41. Public Library of Science 2012-02-01 /pmc/articles/PMC3270019/ /pubmed/22312424 http://dx.doi.org/10.1371/journal.pone.0030330 Text en Curriu et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Curriu, Marta Fausther-Bovendo, Hughes Pernas, María Massanella, Marta Carrillo, Jorge Cabrera, Cecilia López-Galíndez, Cecilio Clotet, Bonaventura Debré, Patrice Vieillard, Vincent Blanco, Julià Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function |
title | Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function |
title_full | Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function |
title_fullStr | Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function |
title_full_unstemmed | Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function |
title_short | Viremic HIV Infected Individuals with High CD4 T Cells and Functional Envelope Proteins Show Anti-gp41 Antibodies with Unique Specificity and Function |
title_sort | viremic hiv infected individuals with high cd4 t cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270019/ https://www.ncbi.nlm.nih.gov/pubmed/22312424 http://dx.doi.org/10.1371/journal.pone.0030330 |
work_keys_str_mv | AT curriumarta viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT faustherbovendohughes viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT pernasmaria viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT massanellamarta viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT carrillojorge viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT cabreracecilia viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT lopezgalindezcecilio viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT clotetbonaventura viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT debrepatrice viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT vieillardvincent viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction AT blancojulia viremichivinfectedindividualswithhighcd4tcellsandfunctionalenvelopeproteinsshowantigp41antibodieswithuniquespecificityandfunction |